Back
Speaker illustration

undefined undefined undefined

Presentations

Low dose rivaroxaban therapy in aspirin allergic patients undergoing percutaneous coronary intervention

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Coronary artery disease - Pharmacotherapy 3

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources